- Execution rate: 1 share - 1 voting right
- Planned Meeting time: August 2026
The date of the 2026 Annual General Meeting will be announced to shareholders in the Meeting Invitation, posted on the Company's website and in the mass media as prescribed by prevailing laws.
- Meeting venue: to be organized at the headquarters of Lam Dong Pharmaceutical Joint Stock Company (Ladophar), address: No. 18 Ngo Quyen, Cam Ly Ward - Da Lat, Lam Dong Province.
- Meeting agenda:
+ 2025 Reports 
+ 2026 Business Plan
+ 2025 Audited Financial Statements 
+ Selection of an Auditor for 2026;
+ Other issues within the authority of the General Meeting (to be announced in the invitation letter and published the information on the Company's Website before the date of the General Meeting)
Coordination details and procedures for corporate action processing for holders of the above securities between VSDC, the Securities registering institution and depository members are specified in the Guideline on corporate action processing for securities holders at VSDC.
Lamdong Pharmaceutical Joint Stock Company and the parties involved in the process of preparing the dossier, documents of corporate action processing are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of records and documents shall be legally responsible within the scope related to such records and documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.